These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 19609669

  • 1. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells.
    Qu Y, Wang J, Sim MS, Liu B, Giuliano A, Barsoum J, Cui X.
    Breast Cancer Res Treat; 2010 Jun; 121(2):311-21. PubMed ID: 19609669
    [Abstract] [Full Text] [Related]

  • 2. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418
    [Abstract] [Full Text] [Related]

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA, Di X, Walker TD, Sawyer ST.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [Abstract] [Full Text] [Related]

  • 5. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY, Small GW, Orlowski RZ.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678
    [Abstract] [Full Text] [Related]

  • 6. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 7. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Hossain DM, Banerjee S, Das K, Sa G, Das T.
    Carcinogenesis; 2010 Feb 15; 31(2):259-68. PubMed ID: 19969555
    [Abstract] [Full Text] [Related]

  • 8. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.
    Clin Cancer Res; 2005 Oct 15; 11(20):7490-8. PubMed ID: 16243823
    [Abstract] [Full Text] [Related]

  • 9. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.
    Exp Cell Res; 2008 Feb 01; 314(3):509-29. PubMed ID: 18061162
    [Abstract] [Full Text] [Related]

  • 10. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.
    Tran MA, Smith CD, Kester M, Robertson GP.
    Clin Cancer Res; 2008 Jun 01; 14(11):3571-81. PubMed ID: 18519791
    [Abstract] [Full Text] [Related]

  • 11. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW, Shi YY, Higgins LS, Orlowski RZ.
    Cancer Res; 2007 May 01; 67(9):4459-66. PubMed ID: 17483361
    [Abstract] [Full Text] [Related]

  • 12. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.
    Oncogene; 2011 Jul 14; 30(28):3139-52. PubMed ID: 21317920
    [Abstract] [Full Text] [Related]

  • 13. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H, Jiang C, Ip C, Rustum YM, Lü J.
    Clin Cancer Res; 2005 Mar 15; 11(6):2379-88. PubMed ID: 15788689
    [Abstract] [Full Text] [Related]

  • 14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 15. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 01; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 16. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
    Yeh CT, Wu CH, Yen GC.
    Mol Nutr Food Res; 2010 Sep 01; 54(9):1285-95. PubMed ID: 20352621
    [Abstract] [Full Text] [Related]

  • 17. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL, Kuo PL, Lin LT, Lin CC.
    J Pharmacol Exp Ther; 2005 Apr 01; 313(1):333-44. PubMed ID: 15626723
    [Abstract] [Full Text] [Related]

  • 18. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F, Matsubara T, Tsurukai T, Hata K, Nishimura R, Yoneda T.
    J Bone Miner Res; 2008 Jun 01; 23(6):907-14. PubMed ID: 18251700
    [Abstract] [Full Text] [Related]

  • 19. An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.
    Mamay CL, Mingo-Sion AM, Wolf DM, Molina MD, Van Den Berg CL.
    Oncogene; 2003 Jan 30; 22(4):602-14. PubMed ID: 12555073
    [Abstract] [Full Text] [Related]

  • 20. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW, Kim SG, Kim HP, Kwon E, You J, Choi HJ, Park JH, Kang BC, Im SA, Kim TY, Kim WH, Bang YJ.
    Cancer Res; 2008 Mar 15; 68(6):1916-26. PubMed ID: 18339873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.